Arnold R Gammaitoni
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 29, 2023
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.John Cha, Gregory Filatov, Steven J Smith
|Aug 06, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.Joseph Sullivan, Lieven Lagae, J Helen Cross
|Oct 05, 2022
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.Kelly G Knupp, Ingrid E Scheffer, Berten Ceulemans
|Jul 08, 2022
An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.Renzo Guerrini, Nicola Specchio, Ángel Aledo-Serrano
|Oct 22, 2021
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysis.Joseph Sullivan, Nicola Specchio, Orrin Devinsky
|Oct 20, 2020
Fenfluramine HCl (Fintepla<sup>®</sup> ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study.Joseph Sullivan, Ingrid E Scheffer, Lieven Lagae
Pageof 1
Frequent Collaborators
4 joint publications
Bradley S Galer
3 joint publications
Lieven Lagae
3 joint publications
Renzo Guerrini
2 joint publications
Nicola Specchio
2 joint publications
Tilman Polster
2 joint publications
Adam Strzelczyk
2 joint publications
Joseph Sullivan
2 joint publications
Orrin Devinsky
2 joint publications
Ingrid E Scheffer
2 joint publications
Kelly G Knupp
